Entero Regains Nasdaq Compliance With Grid AI Acquisition
-
NBA bans Mitchell, Champagnie one game for sparking melee
-
'Project Hail Mary' rockets to top of N. America box office
-
Syrians protest alcohol sale limits, curbs on personal freedom
-
Spurs can '100 percent' avoid nightmare of relegation: Saltor
-
Araujo header scrapes Liga leaders Barcelona win over Rayo
-
Israel launches strikes as Lebanon warns of invasion
-
Torrential rains in Kenya kill 81 in March: officials
-
Iran threatens Mideast infrastructure after Trump ultimatum
-
Spurs felled by Forest in relegation battle, Sunderland shock Newcastle
-
Spurs collapse against Forest, failing acid test
-
US may 'escalate to de-escalate' against Iran: Treasury chief
-
Howe disappointed in himself after 'painful' Newcastle defeat
-
Quansah to miss England's pre-World Cup friendlies
-
Araujo header scrapes Liga leaders Barca win over Rayo
-
Georgia buries Patriarch Ilia II as succession stirs fears of Russian influence
-
DeChambeau wins back-to-back LIV Golf play-offs
-
Sunderland inflict more derby pain on Newcastle
-
Nepali youth demand release of govt report into deadly September uprising
-
US, Iran trade threats to target infrastructure in Middle East
-
Paris doubles up with super-G victory at World Cup finals
-
Dortmund part ways with sporting director Kehl
-
Russia resumes use of space launch site damaged in accident
-
Cuba scrambles to restore power after new blackout
-
Senegal's Idrissa Gueye ready to 'hand back' AFCON medals
-
New Zealand's Walsh bags fourth world indoor gold
-
Goggia claims first super-G title after victory in Kvitfjell
-
Slovenia votes in tight polls, with conservatives eyeing comeback
-
A herd stop: Train kills 3 rare bison in Poland
-
Vietnam, Russia to sign energy deal: Hanoi
-
American Gumberg triumphs in Hainan for second DP World Tour win
-
South Africa clinch 19-run win over New Zealand in fourth T20
-
Iran threatens Middle East infrastructure after Trump ultimatum
-
French elect mayors in key cities including Paris
-
'They beat us with whips': Sudan RSF detainees tell of horrors in El-Fasher
-
Australia's Hannah Green wins historic third tournament in a row
-
China's premier vows to expand global 'trade pie': state media
-
Belgium commemorates Brussels attacks 10 years on
-
Sri Lanka raises fuel prices by 25 percent as war bites
-
Rights groups fear use of arrest to stifle free speech in Pakistan
-
Iranian missiles sow panic, destruction in Israeli towns
-
Damaged Russian tanker to be towed to Libya: state-owned company
-
Gilgeous-Alexander scores 40, LeBron breaks NBA appearance record
-
Cuba hit by second nationwide blackout in a week
-
BTS draws over 100,000 fans to Seoul comeback concert: label
-
US-China 'Board of Trade' may help ties but experts flag market worries
-
Sinner, defending champ Mensik advance to third round at Miami Open
-
Iran missile strikes wound over 100 in two south Israel towns
-
Hannah Green Secures Hat Trick with Statement Win at Australian Women's PGA Championship
-
6 Reasons Why FR Clothing Is Nonnegotiable in Construction Uniform Services
-
How to Cut Unnecessary Expenses Without Sacrificing Comfort
Entero Regains Nasdaq Compliance With Grid AI Acquisition
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. ("Grid AI"), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule").
Entero's publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of Entero, enables the Company to participate in one of the most significant secular growth arenas of the coming decade: hyperscale data centers, grid‑edge orchestration, and AI‑driven infrastructure optimization.
Forward‑Looking Statements
This press release contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the strategic benefits of the acquisition, the integration of Grid AI, the ability to maintain compliance with Nasdaq's listing criteria in connection with the Grid AI acquisition and otherwise, the ability to obtain shareholder approval of the common stock underlying the preferred stock issued in the Grid AI acquisition, expected future operating results, market opportunities, and the Company's growth strategy. Actual results may differ materially due to risks and uncertainties. The Company undertakes no obligation to update forward‑looking statements except as required by law.
About Entero Therapeutics, Inc.
Entero Therapeutics (NASDAQ:ENTO) is a publicly listed company. The Company's programs address significant unmet needs in gastrointestinal (GI) health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following the acquisition of Grid AI, the Company is continuing these prior operations and is also repositioning into the infrastructure, AI and data‑centre orchestration space. Entero operates Grid AI as a wholly‑owned subsidiary and intends to leverage its public‑market listing and corporate resources to scale the new venture.
About Grid AI
Grid AI is an AI‑driven, grid‑edge software and device orchestration platform enabling business, utility, and hyperscaler customers to forecast, optimize, and dispatch flexible demand, DERs and compute assets. The platform supports major ML frameworks, offers rapid scale across cloud GPU/CPU infrastructure, and is designed to deliver SaaS‑like recurring revenue.
Investor & Media Contacts:
Entero Investor Relations
[email protected]
SOURCE: Entero Therapeutics, Inc.
View the original press release on ACCESS Newswire
M.A.Colin--AMWN